[go: up one dir, main page]

MX2014000781A - Dosis combinada fija de bimatoprost y brimonidina. - Google Patents

Dosis combinada fija de bimatoprost y brimonidina.

Info

Publication number
MX2014000781A
MX2014000781A MX2014000781A MX2014000781A MX2014000781A MX 2014000781 A MX2014000781 A MX 2014000781A MX 2014000781 A MX2014000781 A MX 2014000781A MX 2014000781 A MX2014000781 A MX 2014000781A MX 2014000781 A MX2014000781 A MX 2014000781A
Authority
MX
Mexico
Prior art keywords
brimonidine
bimatoprost
combined dosage
fixed combined
fixed
Prior art date
Application number
MX2014000781A
Other languages
English (en)
Inventor
Richard S Graham
Anuradha V Gore
Chetan P Pujara
Kevin S Warner
Sesha Neervannan
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of MX2014000781A publication Critical patent/MX2014000781A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se refiere a composiciones que comprenden combinaciones de brimonidina y brimatoprost útiles para disminuir la presión intraocular en un paciente y para el tratamiento del glaucoma.
MX2014000781A 2011-07-20 2012-07-20 Dosis combinada fija de bimatoprost y brimonidina. MX2014000781A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161509666P 2011-07-20 2011-07-20
PCT/US2012/047586 WO2013013143A1 (en) 2011-07-20 2012-07-20 Fixed dose combination of bimatoprost and brimonidine

Publications (1)

Publication Number Publication Date
MX2014000781A true MX2014000781A (es) 2014-04-30

Family

ID=46599013

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014000781A MX2014000781A (es) 2011-07-20 2012-07-20 Dosis combinada fija de bimatoprost y brimonidina.

Country Status (14)

Country Link
US (2) US20130023536A1 (es)
EP (1) EP2734206A1 (es)
JP (2) JP2014520895A (es)
KR (1) KR20140056280A (es)
CN (1) CN103747786A (es)
AU (1) AU2012283895A1 (es)
BR (1) BR112014001118A2 (es)
CA (1) CA2841969A1 (es)
CO (1) CO6880070A2 (es)
IL (1) IL230450A0 (es)
MX (1) MX2014000781A (es)
PH (1) PH12014500179A1 (es)
RU (1) RU2014103544A (es)
WO (1) WO2013013143A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104114154A (zh) * 2011-12-16 2014-10-22 阿勒根公司 包含聚乙烯基己内酰胺-聚乙酸乙烯酯-聚乙二醇接枝共聚物(Soluplus)的眼用组合物
EP2841104A1 (en) * 2012-04-24 2015-03-04 Allergan, Inc. Prostaglandin and vasoconstrictor pharmaceutical compositions and methods of use
NO2753788T3 (es) * 2013-05-10 2018-06-16
WO2014186504A1 (en) 2013-05-15 2014-11-20 Topokine Therapeutics, Inc. Methods and compositions for topical delivery of prostaglandins to subcutaneous fat
ES2838756T3 (es) * 2014-01-24 2021-07-02 Sentiss Pharma Private Ltd Composición farmacéutica que comprende brinzolamida
ES2954412T3 (es) * 2014-10-20 2023-11-22 Sentiss Pharma Private Ltd Solución oftálmica
TWI699205B (zh) * 2014-12-12 2020-07-21 日商興和股份有限公司 用於預防或治療青光眼之藥物療法
JP2018509473A (ja) * 2015-03-24 2018-04-05 ダウ グローバル テクノロジーズ エルエルシー ポリマーの水溶液
PL3103439T3 (pl) * 2015-06-09 2019-12-31 Medproject Pharma-Entwicklungs- Und Vertriebsgesellschaft Mbh Zdolny do tworzenia kropli oftalmiczny żel bimatoprostu
US20180353504A1 (en) * 2017-06-08 2018-12-13 Eye Therapies, Llc Low-dose brimonidine combinations and uses thereof
KR102115285B1 (ko) * 2017-06-22 2020-05-26 연성정밀화학(주) 녹내장 치료용 점안 조성물
JP7170436B2 (ja) * 2017-06-28 2022-11-14 千寿製薬株式会社 水溶性高分子を含む点眼剤
WO2020219707A1 (en) * 2019-04-24 2020-10-29 Allergan, Inc. Compositions and methods for treatment of ocular conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2001A (en) * 1841-03-12 Sawmill
WO1996013267A2 (en) * 1994-10-27 1996-05-09 Allergan Combinations of prostaglandins and brimonidine or derivatives thereof for the treatment of glaucoma

Also Published As

Publication number Publication date
US20130023536A1 (en) 2013-01-24
KR20140056280A (ko) 2014-05-09
EP2734206A1 (en) 2014-05-28
BR112014001118A2 (pt) 2017-02-14
CA2841969A1 (en) 2013-01-24
CO6880070A2 (es) 2014-02-28
RU2014103544A (ru) 2015-08-27
IL230450A0 (en) 2014-03-31
US20140249153A1 (en) 2014-09-04
AU2012283895A1 (en) 2014-02-06
PH12014500179A1 (en) 2014-03-24
WO2013013143A1 (en) 2013-01-24
JP2014520895A (ja) 2014-08-25
CN103747786A (zh) 2014-04-23
JP2015110672A (ja) 2015-06-18

Similar Documents

Publication Publication Date Title
MX2014000781A (es) Dosis combinada fija de bimatoprost y brimonidina.
UY34918A (es) Nuevos ácidos 5-aminotetrahidroquinolin-2-carboxílicos y su uso
MX2013002864A (es) Triazina-oxadiazoles.
EA201301240A1 (ru) Полиморфная форма бензоата линаглиптина
MY171920A (en) Prevention and treatment of ocular conditions
CO6491060A2 (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
IN2014DN09434A (es)
DOP2017000013A (es) Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
ECSP13012368A (es) Composiciones farmacéuticas de co-cristales de tramadol y coxibs
UA114705C2 (uk) Андрогенна композиція для лікування офтальмологічного захворювання
CO6640327A2 (es) Compuestos de pirazol como inhibidores del receptor sigma
BR112015009228A8 (pt) Formulação farmacêutica líquida estéril e forma de dosagem intraocular oftálmica líquida estéril para injeção
ECSP13012494A (es) Inhibidores de oxadiazol de la producción de leucotrieno.
GT201400131A (es) Derivados de dihidro-benzo-oxazina y dihidro-pirido-oxazina
MX356728B (es) Combinación farmacéutica para usar en el tratamiento de pacientes que padecen diabetes de tipo 2.
MX2021005052A (es) Oxiesteroles y métodos de uso de los mismos.
MX2015000442A (es) Composiciones vacuna.
BR112013030554A2 (pt) forma cristalina de ciclosporina a, métodos de preparação e métodos para uso da mesma
MX360554B (es) Composiciones que comprenden y metodos que utilizan inhibidores de co-transportadores de glucosa-sodio 1 y 2.
CO6561789A2 (es) Método de tratamiento
TR201818754T4 (tr) Koruyucu içermeyen Brimonidin Ve Timolol Çözeltileri
CO7160080A2 (es) Composiciones lipídicas de racecadotrillo
MX2016000294A (es) Composicion farmaceutica para liberacion sostenida de lanreotida.
DOP2015000176A (es) Compuestos de azetidiniloxifenilpirrolidina
CR20130318A (es) Nuevos compuestos de benzodioxol-piperazina

Legal Events

Date Code Title Description
FA Abandonment or withdrawal